Speech-Language Pathologists in Rantoul, IL Accepting Medicare

10 Speech-Language Pathologists found. Showing 1 - 10

Mrs. Ginger Ann Hubner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E Wabash Ave, Rantoul, IL 61866 Phone: 217-893-5400

Tara Lynn Kiser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 650 N Maplewood Dr, Rantoul, IL 61866 Phone: 217-892-2131

Allyson Magno, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 S Sheldon St, Rantoul, IL 61866 Phone: 217-892-2151

Mary Moran Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 650 N Maplewood Dr, Rantoul, IL 61866 Phone: 217-893-5404

Meredith Anne Adams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 722 Stonebridge Center Rd, Rantoul, IL 61866 Phone: 217-282-9854

Maureen Dickman, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1625 Short St, Rantoul, IL 61866 Phone: 217-893-4141

Chasity Kay Thompson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E Wabash Ave, Rantoul, IL 61866 Phone: 217-893-5401

Mrs. Erin Christine Kelly, MS,CCC-SLP/L Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 722 Stonebridge Center Rd, Rantoul, IL 61866 Phone: 309-826-1253

Mallory Anning, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E Wabash Ave, Rantoul, IL 61866 Phone: 217-893-5400

Melina Helen Thompson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E Wabash Ave, Rantoul, IL 61866 Phone: 217-893-5401

News Archive

Novel therapeutic approach for treatment of leukemia

The BCR/ABL gene, which does not occur among healthy people, has been shown to be a causative agent in the pathogenesis of B-cell acute lymphocytic leukemia.

Serenity Pharmaceuticals enters agreement with Allergan for nocturia product candidate

CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.

Attention intimately linked to how people learn about danger, study shows

A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.

Tai Chi intervention offers anti-aging benefits, says study

Tai Chi, a traditional Chinese martial art and sport, has been found to be beneficial in raising the numbers of an important type of cell when three groups of young people were tested to discover the benefits of Tai Chi, brisk walking or no exercise.

Read more Medical News

› Verified 2 days ago